Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|December 15, 2019
Targeting ATR as Cancer Therapy: A new era for synthetic lethality and synergistic combinations?Alice Bradbury, Sally Hall, Nicola Curtin, et al.
Cancers|April 28, 2017
Targeting the ATR-CHK1 Axis in Cancer TherapyStuart Rundle, Alice Bradbury, Yvette Drew, et al.
Cells|August 12, 2022
The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of ResponseAlice Bradbury, Frank T Zenke, Nicola J Curtin, et al.
Cancers|July 26, 2020
Characterisation of Ovarian Cancer Cell Line NIH-OVCAR3 and Implications of Genomic, Transcriptomic, Proteomic and Functional DNA Damage Response Biomarkers for Therapeutic TargetingAlice Bradbury, Rachel O'Donnell, Yvette Drew, et al.
Nursing Management|February 26, 2021
A nurse staffing model for an unprecedented eventKimberly Cross, Alice Bradbury, Nikki Burnham, et al.
Cancers|April 3, 2021
Genomic, Transcriptomic, and Functional Alterations in DNA Damage Response Pathways as Putative Biomarkers of Chemotherapy Response in Ovarian CancerSweta Sharma Saha, Lucy Gentles, Alice Bradbury, et al.
Cancer Medicine|August 16, 2018
Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumorMiriam Franklin, Lucy Gentles, Elizabeth Matheson, et al.
Haematologica|March 24, 2018
DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 statusSrdana Grgurevic, Patricia Montilla-Perez, Alice Bradbury, et al.
Pageof 1